Infectious Diseases (all articles)
Small Study Shows No Evidence of Secondary Transmission of COVID-19 from Children Attending School
29 May, 2020 | 03:14h | UTC
Study: Face Mask Use in Households May Reduce Secondary Transmission of SARS-CoV-2
29 May, 2020 | 03:15h | UTCCommentaries: Wearing face masks at home might help ward off COVID-19 spread among family members – BMJ AND Expert reaction to study looking at face masks in the home – Science Media Centre
[Abstract Only] Meta-Analysis: Postoperative Continuation of Antibiotic Prophylaxis Does Not Reduce the Incidence of Surgical Site Infections
29 May, 2020 | 03:09h | UTC
WHO Interim Guidance: Clinical Management of COVID-19
28 May, 2020 | 10:02h | UTCClinical management of COVID-19 – World Health Organization
Face Coverings for the Public: Laying Straw Men to Rest, by Trisha Greenhalgh
28 May, 2020 | 09:57h | UTCFace coverings for the public: Laying straw men to rest – Journal of Evaluation in Clinical Practice
Related: Face coverings for the lay public: an alternative view – CEBM Oxford AND Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach – Annals of Internal Medicine
https://twitter.com/EricTopol/status/1265640531016552449
Systematic Review: Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
28 May, 2020 | 09:59h | UTC
Perspective: Reducing Transmission of SARS-CoV-2
28 May, 2020 | 09:55h | UTCReducing transmission of SARS-CoV-2 – Science
Remdesivir for Covid-19: A 5-day Course is Similarly Effective as a 10-day Course
28 May, 2020 | 10:00h | UTCRemdesivir for 5 or 10 Days in Patients with Severe Covid-19 – New England Journal of Medicine
Review of Trials Currently Testing Treatment and Prevention of COVID-19
28 May, 2020 | 09:48h | UTC
[Preprint] No Evidence for Increased Transmissibility from Recurrent Mutations in SARS-CoV-2
28 May, 2020 | 09:47h | UTCNo evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 – bioRxiv
Herd Immunity: Understanding COVID-19
28 May, 2020 | 09:45h | UTCHerd Immunity: Understanding COVID-19 – Immunity
Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore
28 May, 2020 | 09:44h | UTCCommentaries: People Are Still Terrible at Correctly Using Medical-Grade Face Masks And Respirators – Science Alert AND Study Casts Doubt on N95 Masks for the Public – MedPage Today (free registration required)
WHO: Revealing the Toll of COVID-19 – A Technical Package for Rapid Mortality Surveillance and Epidemic Response
27 May, 2020 | 02:48h | UTC
Related Commentary on Twitter
Countries need real-time mortality data for an effective #COVID19 response.
WHO together with @VitalStrat & @AfricaCDC released a new technical package on rapid mortality surveillance https://t.co/NeIZFNW774#WorldHealthData pic.twitter.com/5HcDjfXxBD
— World Health Organization (WHO) (@WHO) May 25, 2020
Perspective: Fast and Frugal Innovations in Response to the COVID-19 Pandemic
27 May, 2020 | 02:33h | UTCFast and frugal innovations in response to the COVID-19 pandemic – Nature Medicine
Related Commentary on Twitter
https://twitter.com/trishgreenhalgh/status/1265215886178336768
“Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic
27 May, 2020 | 02:39h | UTC
Study: Loss of Smell and Taste in 2013 Patients with Mild to Moderate COVID-19
27 May, 2020 | 02:35h | UTC
CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19
27 May, 2020 | 02:37h | UTC“I think or know I had COVID-19, and I had symptoms.”
You can be with others after:
- 3 days with no fever AND
- Symptoms improved AND
- 10 days since symptoms first appeared”
Perspective: The Totality of the Evidence, by Dr. John Ioannidis
27 May, 2020 | 02:29h | UTCThe Totality of the Evidence – Boston Review
See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science
“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”
Just the Facts: What Drugs are Safe and Effective for COVID-19?
27 May, 2020 | 02:31h | UTCRelated Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
“Apart from supportive care, there are no current effective therapeutics for COVID-19”
A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2
27 May, 2020 | 02:22h | UTCA Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal
Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19
27 May, 2020 | 02:21h | UTC
Lyme Borreliosis: Diagnosis and Management
27 May, 2020 | 02:19h | UTCLyme borreliosis: diagnosis and management – The BMJ (free for a limited period)
Study Shows Abnormalities in Placentas from COVID-19-positive Pregnant Women
26 May, 2020 | 10:00h | UTCPlacental Pathology in COVID-19 – American Journal of Clinical Pathology
Commentaries: Placentas from COVID-19-positive pregnant women show injury – Northwestern University AND Expert reaction to study looking at placentas from COVID19-positive pregnant women – Science Media Centre AND Covid-19 appears to attack placenta during pregnancy, study says – CNN AND Placenta Injury Observed in Pregnant Women Who Test Positive For Coronavirus – Forbes
SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines
26 May, 2020 | 10:02h | UTC
Perspective: In Pandemic, Many Seeing Upsides to Telemedicine
26 May, 2020 | 09:52h | UTCPart I: In pandemic, many seeing upsides to telemedicine – CIDRAP
Part II: COVID-19 reveals telehealth barriers, solutions – CIDRAP